SEC asks Bharat Serums to revise phase I/II trial protocols for equine antiserum to treat COVID-19
The SEC has recommended grant of permission to conduct the clinical trial provided the company submits the revised clinical trial…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.